Natco Pharma informs about press release

18 Dec 2017 Evaluate

Natco Pharma has informed about press release on launching TAFNAT, Tenofovir Alafenamide tablets, for treatment of chronic hepatitis B, in INDIA

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

890.40 -13.15 (-1.46%)
01-Jan-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.55
Dr. Reddys Lab 1254.70
Cipla 1503.65
Zydus Lifesciences 908.85
Lupin 2084.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×